NCT01306123View on ClinicalTrials.gov

Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Focus: Bioavailability
Interventions
DRUG

Nascobal nasal spray (cyanocobalamin, USP)

Single intranasal administration

DRUG

Vitamin B12-ratiopharm N, injection solution

One single intramuscular administration

Trial Locations (1)

141 86

Karolinska Trial Alliance, Karolinska University Hospital, Huddinge, Stockholm

Sponsors
All Listed Sponsors
lead

Swedish Orphan Biovitrum

INDUSTRY